Iron-related proteins: candidate urine biomarkers in childhood HIV-associated renal diseases.

BACKGROUND Because of the risk of performing renal biopsies in children with co-morbid conditions, we carried out this study to identify candidate protein biomarkers in the urine of HIV-infected children with renal disease. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS Urine samples from HIV-infected children with biopsy proven HIV-nephropathy (HIVAN; n = 4), HIV-associated Hemolytic Uremic Syndrome (HIV-HUS; n = 2), or no renal disease (n = 3) were analyzed by two-dimensional electrophoresis (2-DE) and proteomic methods. Positive findings were confirmed in HIV-infected children with (n = 20) and without (n = 10) proteinuria using commercially available assays. RESULTS By 2-DE analysis, a single urine marker was not sufficient to distinguish children with HIVAN from the others. High urine levels of beta(2)-microglobulin and retinol-binding protein (RBP) suggested the presence of tubular injury. In addition, we found elevated urine levels of iron and the iron-related proteins, transferrin, hemopexin, haptoglobin, lactoferrin, and neutrophil gelatinase-associated lipocalin (NGAL), in children with HIVAN and HIV-HUS. Furthermore, we detected a significant accumulation of iron in the urine and kidneys of HIV-transgenic (Tg) rats with renal disease. CONCLUSION These findings suggest that iron and iron-related proteins might be promising candidate urine biomarkers to identify HIV-infected children at risk of developing HIVAN and HIV-HUS. Moreover, based on the results of previous studies, we speculate that the release or accumulation of iron in the kidney of HIV-infected children may contribute to the rapid progression of their renal disease, and could become a new therapeutic target against HIVAN and HIV-HUS.

[1]  T. Rabelink,et al.  Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. , 2001, Journal of the American Society of Nephrology : JASN.

[2]  A. Prentice,et al.  Elevated Iron Status Strongly Predicts Mortality in West African Adults With HIV Infection , 2007, Journal of acquired immune deficiency syndromes.

[3]  J. Church.  Proteinuria in Children Infected With the Human Immunodeficiency Virus , 2008, Pediatrics.

[4]  M. Endo,et al.  Urinary Complement Factor H in Renal Disease , 2002, Nephron.

[5]  S. Gupta,et al.  Serum ferritin in acquired immune deficiency syndrome. , 1986, Journal of clinical & laboratory immunology.

[6]  N. Vaziri,et al.  Association of Renal Injury with Increased Oxygen Free Radical Activity and Altered Nitric Oxide Metabolism in Chronic Experimental Hemosiderosis , 2000, Laboratory Investigation.

[7]  J. Delanghe,et al.  Hemopexin: a review of biological aspects and the role in laboratory medicine. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[8]  M. Kakei,et al.  Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients. , 2004, Diabetes care.

[9]  K. Yamauchi,et al.  Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment , 1993, Infection and immunity.

[10]  John R Raymond,et al.  Urine biomarkers predict the cause of glomerular disease. , 2007, Journal of the American Society of Nephrology : JASN.

[11]  P. Ray,et al.  Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome , 2001, Pediatric Nephrology.

[12]  N. Vaziri,et al.  The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. , 2004, Kidney international.

[13]  C. Whitty,et al.  Interpreting tests for iron deficiency among adults in a high HIV prevalence African setting: routine tests may lead to misdiagnosis. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  M. Kurdián,et al.  Rust urine after intense hand drumming is caused by extracorpuscular hemolysis. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[15]  R. Black,et al.  Iron supplementation in early childhood: health benefits and risks. , 2006, The American journal of clinical nutrition.

[16]  S. Sidney,et al.  Microalbuminuria in HIV infection , 2007, AIDS.

[17]  C. Alpers.  Light at the end of the TUNEL: HIV-associated thrombotic microangiopathy. , 2003, Kidney international.

[18]  W. Fish,et al.  Rapid colorimetric micromethod for the quantitation of complexed iron in biological samples. , 1988, Methods in enzymology.

[19]  D. Karcher,et al.  Bone marrow macrophage iron grade and survival of HIV-seropositive patients. , 1999, AIDS.

[20]  M. Mitsnefes,et al.  Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. , 2003, Journal of the American Society of Nephrology : JASN.

[21]  P. Kimmel,et al.  Idiotypic IgA Nephropathy in Patients with Human Immunodeficiency Virus Infection , 1992 .

[22]  V. Pardo,et al.  Renal disease in children with the acquired immunodeficiency syndrome , 1990, The New England journal of medicine.

[23]  C. Winkler,et al.  HIV-associated nephropathy in African Americans1 , 2003 .

[24]  F. Denaro,et al.  A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. , 2003, Kidney international.

[25]  A. Alfrey.  Toxicity of tubule fluid iron in the nephrotic syndrome. , 1992, The American journal of physiology.

[26]  A. Vanderver,et al.  Decreased asialotransferrin in cerebrospinal fluid of patients with childhood-onset ataxia and central nervous system hypomyelination/vanishing white matter disease. , 2005, Clinical chemistry.

[27]  L. Kjeldsen,et al.  Characterization of two ELISAs for NGAL, a newly described lipocalin in human neutrophils. , 1996, Journal of immunological methods.

[28]  S. Shah,et al.  Role of iron in progressive renal disease. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  P. Kimmel,et al.  Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. , 1992, The New England journal of medicine.

[30]  R. Thakker,et al.  Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases. , 2000, Kidney international.

[31]  G. Pescarmona,et al.  Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? , 1999, Cell biochemistry and function.

[32]  P. Ray,et al.  Atypical hemolytic uremic syndrome in human immunodeficiency virus-1-infected children , 1997, Pediatric Nephrology.

[33]  K. Mori,et al.  Iron, lipocalin, and kidney epithelia. , 2003, American journal of physiology. Renal physiology.

[34]  P. Ray,et al.  A 20-year history of childhood HIV-associated nephropathy , 2004, Pediatric Nephrology.

[35]  V. Gordeuk,et al.  Iron status and the outcome of HIV infection: an overview. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[36]  A. Bendich,et al.  Free radical tissue damage: protective role of antioxidant nutrients 1 , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  S. Shah,et al.  In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. , 1998, Kidney international.

[38]  S. Goldstein,et al.  Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study , 2007, Critical care.

[39]  S. Shah,et al.  Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. , 1993, The Biochemical journal.

[40]  S. Moestrup,et al.  Plasma protein haptoglobin modulates renal iron loading. , 2005, The American journal of pathology.

[41]  W. Guder,et al.  Markers for the diagnosis and monitoring of renal tubular lesions. , 1992, Clinical nephrology.

[42]  R. Anderson,et al.  Effect of iron on renal tubular epithelial cells. , 1996, Kidney international.

[43]  P. Ray,et al.  Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington, D.C. area: 12 years' experience. , 1998, Seminars in nephrology.

[44]  B. Emmerich,et al.  Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  D. Jacobus.  Randomization to iron supplementation of patients with advanced human immunodeficiency virus disease--an inadvertent but controlled study with results important for patient care. , 1996, The Journal of infectious diseases.

[46]  P. Klotman,et al.  Chapter 47 – HIV-associated Nephropathy , 2009 .

[47]  C. Winkler,et al.  HIV-associated nephropathy in African Americans. , 2003, Kidney international. Supplement.

[48]  G. Gray,et al.  Pathogenesis of Anemia During Human Immunodeficiency Virus Infection , 2001, Journal of Investigative Medicine.

[49]  A. Shevchenko,et al.  Sample preparation methods for mass spectrometric peptide mapping directly from 2-DE gels. , 1999, Methods in molecular biology.

[50]  B. S. van Asbeck,et al.  Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. , 2000, The Journal of infectious diseases.